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The primary goals of the work presented in this thesis were to better understand how metal 
nanoparticles (MNPs) affect antimicrobial activity, and to develop green synthesis protocols for 
the fabrication of nanocomposites designed specifically for antimicrobial applications. This work 
utilized a meta-analytical framework to mine data from recent literature and determine which MNP 
physiochemical properties dictate their antibacterial activity. Linear regression models revealed a 
size dependence for the antibacterial activity of silver MNPs, where smaller nanoparticles are more 
effective at combating Gram-negative E. coli (R2 = 40.3%, p < 0.001). In contrast, surface charge 
was determined to be the dominate physiochemical parameter in predicting the efficacy of silver 
MNPs against Gram-positive S. aureus, with potential secondary dependency on MNP size (R2 < 
44%, p < 0.001 and < 0.05 for charge and size respectively). Better standardization in antimicrobial 
testing and reporting protocols will be critical in allowing for more powerful analyses in the future. 
 Building off of the meta-analytical work, ecofriendly and cost effective synthesis protocols 
were developed to generate copper nanoparticles using cellulose nanocrystals and tannic acid. 
Cellulose nanocrystals provided an effective and environmentally benign base for silver and 
copper MNPs to be deposited using simple one-pot reduction. The developed one-pot synthesis 
method was also shown to be effective for the generation of silver/cellulose and 
copper/silver/cellulose nanomaterials. The final morphology of the copper/cellulose MNPs was 
found to be heavily dependent on the order of reagents during one-pot reduction, where coating of 
tannic acid on cellulose nanocrystals was a necessary first step to generate small and well-
dispersed copper nanoparticles. The copper/cellulose composite was highly effective at 
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1.1 Project Motivation 
Compound threats of the development of extreme antibiotic resistance in bacterial populations 
and the slowdown new antibiotic discovery has led to a dearth of new treatments for bacterial 
infections in humans [1]. With the “golden age of antibiotics” long gone [2], the development of 
new, non-antibiotic antimicrobial agents will be increasing important for the continuing health 
and safety of the world’s population. Metal nanoparticles, which have been generated since 
antiquity for their unique optical properties, have become of interest in the past decades for 
exactly this application [3]. It has been shown that metal nanoparticles are effective both against 
common culture strains [4] and against multi-drug resistant strains [5] of human-infecting 
pathogens, lending promise to the development of metal nanoparticle-based treatment regimes. 
However, to date, little to no work has been done on the clinical application of antimicrobial 
nanoparticles [6]. The clinical relevance of metal nanoparticles is in large part hindered because 
there is not yet a consensus on how they actually function in the suppression or killing of 
bacteria, nor is there a proven methodology to what makes a nanoparticle maximally effective 
for this application.  
A more rigorous understanding of what makes metal nanoparticles effective is crucial to 
the translation of these particles from bench to clinic. Determining from the literature what 
physiochemical parameters are important is challenging due to the high variance in the generated 
nanoparticles, in the testing procedures, and in the reporting standards. This variance makes it 
nearly impossible to draw meaningful conclusions about what parameters are or are not 
important through the comparison of individual articles. A larger and more robust analysis of the 
literature is needed to determine what overarching trends exist, and this can be achieved through 




population size and discern trends despite the noise introduced by high inter-study variance, and 
meta-analytical results are therefore more reliable for clinical translation [7]. 
Additionally, many antimicrobial metal nanoparticles are generated using highly toxic 
chemicals, such as sodium borohydride [8] or hydrazine [9], increasing the downstream risk of 
cyto- and ecotoxicity. Even when the understanding of metal nanoparticles’ antimicrobial 
activity is improved, they will not be translatable until they can be fabricated with sustainable 
and eco-friendly techniques. The ‘green’ fabrication of metal nanoparticles is becoming a more 
prevalent area of research, with a large body of research being published on the use of plant 
extracts and plant-derived compounds to synthesis metal nanoparticles [10]. However, work 
remains to be done in the controlled and specific green fabrication of antimicrobial metal 
nanoparticles. The combination of a thorough understanding of what makes metal nanoparticles 
optimally antimicrobial and how to fabricate nanoparticles fitting these specifications with green 
techniques will be an important goal in the generation of clinically relevant solutions. 
 
1.2 Project Outcomes 
The overall goal of this project was to understand and create potent new antimicrobials material 
with minimal negative environmental impact. This was achieved in two simultaneous thrusts: a 
theoretical component using data mining to clarify what nanoparticle properties are critical for 
antimicrobial applications, and an applied component on the fabrication and characterization of 
antimicrobial metal nanoparticles. 
The first section of this thesis focused on a theoretical approach to determining what 
makes metal nanoparticles maximally effective for antimicrobial applications. In this work, data 
mining and meta-analysis was employed to draw new knowledge from pre-existing literature on 




physiochemical parameters were explored using linear regression models. Both single and 
multivariate models were used to explore the possibility of interaction terms between important 
physiochemical parameters. 
The second section of this thesis describes the fabrication and characterization of a 
versatile composite of cellulose nanocrystals and copper, silver, or copper and silver 
nanoparticles. The impact of fabrication parameters was evaluated to determine optimal 
fabrication conditions and understand how the fabrication process impacts the final material. The 
system was then proven to be useable for the fabrication of multiple types of metal nanoparticles, 
suggesting it’s broader applicability for a variety of projects. A preliminary assessment of 
antimicrobial activity was undertaken. The green system uses a one-pot fabrication method with 
water as the only solvent, and plant-derived reagents, which minimizes any negative 
environmental impact the fabrication process may have. The developed CNC/metal composites 
show promise as an ecofriendly, scalable, and tunable antimicrobial system. 
1.3 Thesis Outline 
This thesis consists of five chapters. The first chapter provides an introduction to the project, 
including the motivation and outcomes. The second chapter reviews the recent literature on 
antimicrobial nanoparticles, highlighting both what is known of their antimicrobial activity and 
how nanoparticles have previously been synthesized. The ecofriendly synthesis of metal 
nanoparticles is highlighted. Chapter three presents the results of the undertaken meta-analysis, 
providing insight into what does and does not influence the antimicrobial activity of metal 
nanoparticles. Chapter four builds off of the work presented in three and explores the novel green 
synthesis of metal nanoparticles theoretically optimized for antimicrobial application. Chapter 








2.1 Background on Antibiotic Resistance 
Each year, bacterial infections cause severe illness around the world, and the rise of antibiotic 
resistance in bacteria means that more and more severe illnesses will develop as time goes on 
[11]. Current reports suggest that at least 26% of reported bacterial infections in Canada alone 
are resistant to at least one class of first-line antibiotics, and as it stands, reversing antibiotic 
resistance is immensely challenging at a community level [12]. These drug-resistant infections 
are associated with one billion dollars in annual healthcare spending in Canada alone [13], and 
this spending is predicted to increase as drug resistant infections continue to proliferate.  
Antibiotics were first used clinically in the 1910s with the synthesis of salvarsan, an 
organoarsenic compound and the first modern antibiotic [14]. Since then, a large number of 
antibiotics have been developed and commercialized for widespread use. However, the number 
of antibiotic compounds being isolated and commercialized has dropped significantly in recent 
decades, with the most recent new class of antibiotics being discovered in the mid-1980s [2]. 
Most antibiotics are derived from bacteria or fungi, which produce antibiotic compounds to 
suppress or kill competing microbes or to mediate interactions with eukaryotic hosts [15]. 
However, because antibiotic compounds are naturally occurring, there is a chance for bacteria to 
evolve resistant to these compounds, and the evolution is accelerated by overuse and misuse of 
antibiotics in human populations [16]. It is therefore crucial to develop novel solutions to address 
the impending antibiotic resistance crisis. 
Nanoparticles, which are materials with at least one dimension of less than 100 nm and 
physiochemical properties significantly different from their bulk state, have gained attention as a 
potential solution to the antibiotic resistance crisis [17]. Most nanoparticles, including organic 
materials such as carbon nanotubes and graphene sheets, and inorganic materials such as 




Metal nanoparticles in particular are promising antibacterial agents, due to their relatively low 
cost and ease of fabrication [19]. Metal nanoparticles with antimicrobial properties have been 
suggested for use in a wide range of applications, including in fabric or surface coating [20], 
[21], in food packaging [22], and in medical supplies such as hospital surfaces [23], [24] and 
catheters [25]. This literature review will discuss the current understandings of how metal 
nanoparticles can act as effective antimicrobial agents, as well as the various methods for 
synthesizing metal nanoparticles. Special emphasis is placed on the ‘green’ or sustainable 
synthesis of metal nanoparticles for antimicrobial applications. 
2.2 Mechanisms of Antimicrobial Activity of Metal 
Nanoparticles 
Despite the wide range of research conducted on antimicrobial nanoparticles, the mechanisms by 
which nanoparticles kill bacteria remain poorly understood. This is in part due to the vast number 
of interactions that these nanoparticles can have with bacterial cells, including electrostatic, 
hydrophobic, stereoselective, ligand-receptor, redox-active, or coordination-based interactions 




[26]. While the exact interactions that lead to bacterial damage or death remain unclear, there are 
many pathways that have been explored as potential contributors. These pathways include 
damage due to physical adsorption of nanoparticles onto the cell (electrostatic or otherwise), 
oxidative damage via nanoparticle catalyzed redox reactions, and damage caused by heavy metal 
ions leached from the nanoparticle surface [27]. Each of these pathways can target a variety of 
biological structures (see Figure 2.1), including the cell membrane [28], DNA [29], and 
organelles [30]. Understanding the exact pathways will be an important step in designing 
optimally antimicrobial and clinically relevant nanoparticles. 
 
2.2.1 Physical Adsorption Dependent Pathways 
In a study conducted by Choi and coworkers, the antimicrobial activity of silver nanoparticles 
was compared to silver ions (from AgNO3) and silver colloids (AgCl) against a variety of 
wastewater-inhabiting bacteria [31]. In a direct comparison, silver nanoparticles were found to be 
more effective at inhibiting bacterial growth than ionic or colloidal silver. When a suspension of 
bacteria and silver nanoparticles was studied using high resolution backscattered scanning 
electron microscopy, the nanoparticles were observed to be physically contacting the bacterial 
cell membranes. Additionally, the bacterial membranes were seen to be pitting, which could be 
attributed to the physical adsorption of the nanoparticles onto the cells. Similar results were 
observed in a study of copper nanoparticle interactions with E. coli [32]. The authors evaluated a 
suspension of bacterial cells and copper nanoparticles using scanning electron microscopy, and 
found that the bacteria displayed unusual morphology, with shrunken, pitted, or otherwise 
disfigured membranes. This effect was attributed to the absorption of copper nanoparticles onto 




The surface charge of antibacterial nanoparticles may also be important in determining 
their antimicrobial efficacy, and for both silver and iron, positively charged nanoparticles are 
more effective than their negatively charged counterparts [33], [34]. While negatively charged 
nanoparticles may be able to bind electrostatically with the positive residues found in many 
bacterial membrane proteins [35], both Gram-positive and Gram-negative bacterial membranes 
bear overall negative charges. Therefore, a positively charged nanoparticle can be expected to be 
more strongly attracted to bacterial cells, becoming more tightly bound and potentially better 
disrupting membrane structure or other cellular processes that occur at the interface. 
A very interesting study by Parashar and coworkers also explored the impact of silver 
ions on the peptidoglycan layer that is present in the outer structures of both Gram-negative and 
Gram-positive bacteria, though in different amounts [36]. The authors modeled the lysozyme 
sensitive bond that connects N-acetylglucosamine and N-acetylmuramic acid within the 
peptidoglycan layer, when alone or in the presence, of 1, 2, and 5 silver ions, as shown in Figure 
2.2. It was found that the bond length stretches with increasing number of silver ions, effectively 
A B 
C 
Figure 2.2: Stretching of the R(C-O) lysozyme sensitive bond by 1, 2, or 5 silver atoms (A). Schematic representation 
of silver-mediated cell membrane damage (B). Transmission electron micrographs of E. coli cells at 1 and 12 hours 
of silver nanoparticle exposure, with red arrows indicating silver nanoparticles and black arrows indicating 




weakening the structure and suggesting the possibility of eventual bond breakage. The authors 
theorized that with enough silver atoms, such as a few hundred in a nanoparticle, the bond could 
be cleaved, destabilizing the cell wall and eventually lysing the cell. This type of destabilization 
could only be achieved when the silver nanoparticles are adhered firmly to the bacterial cell 
membrane, leading the authors to conclude that physical adsorption between the nanoparticle and 
cell is critical to effective antibacterial action. 
Shape dependent nanoparticle behavior has also been observed at the whole-bacteria 
level. In a study by Hong et al. comparing spherical, cubic, and rod shaped silver nanoparticles, 
the cubic nanoparticles were found to be most effective against E. coli [17]. The authors 
proposed that both the cubic and spherical nanoparticles, which have much higher specific 
surface areas than nanorods, were able to pack more tightly to the bacterial cell surfaces, leading 
to increased membrane damage. Differently shaped nanoparticles have also been shown to have 
different interactions with the bacterial proteins that adsorb to their surface, which may cause 
varying states of dysregulation or death of the cell. Soleimani et al. synthesized silver spheres, 
rods, and cubes, and tested their inhibitory affect against E. coli, P. aeruginosa, S. aureus, and B. 
cereus model bacteria [18]. Cube shaped silver nanoparticles were found to be vastly more 
effective at inhibiting all strains of bacteria than any other shape. To uncover the potential 
mechanism, each type of nanoparticle was exposed to human serum albumin, and cubic 
nanoparticles were found to have the highest binding affinity for the proteins. It was theorized 
that nanoparticles with sharp edges were able to aggressively bind with and denature proteins, 
causing increased degradation and cellular damage. However, it is worth noting that unlike the 




killing, this study found that nanorods (both sharp and blunt) where more effective than 
nanospheres. 
 
2.2.2 Redox Dependent Pathways 
The catalysis of biologically damaging reactive oxygen species (ROS) by nanoparticles is 
another pathway by which nanoparticles have been proposed to damage or kill bacteria. Recent 
work by Angelé-Martínez and colleagues sought to understand the damage caused by copper 
oxide nanoparticles through the study of DNA damage [37]. In a comparison of copper ions and 
copper oxide nanoparticles, the damage of nanoparticles was an order of magnitude higher. The 
authors used EPR spectroscopy to evaluate the reactive oxygen species generated by copper 
oxide nanoparticles, and found that hydroxyl radicals were the primary species generated when 
copper oxide particles were incubated with hydrogen peroxide (a common reactive oxygen 
species found in biological environments), while both hydroxyl and super oxide radicals were 
generated in the presence of hydrogen peroxide and ascorbate together. The generation of 
different reactive oxygen species suggests that multiple generation pathways may exist. 
Other work has been conducted looking at the impact of reactive oxygen species 
generated by nanoparticles on bacterial cell membranes. A simple experiment by Ansari et al. 
[38] used scanning electron microscopy to study changes in bacteria exposed to silver 
nanoparticles. The authors observed massive pitting in E. coli’s cell membranes when exposed to 
silver nanoparticles, which they attributed to ROS-mediated damage to the cell membrane. 
Fenton and Fenton-like chemistry, which is the generation of reactive oxygen species by heavy 
metal ions, has been shown to initiate the peroxidation of lipids, leading to catastrophic 
membrane failure [39]. Further studies have corroborated these results using reactive oxygen 




reactive oxygen species [40]. One such study found that after just two hours of incubation with 
silver nanoparticles, 40% of exposed E. coli cells showed significant reactive oxygen species 
related damage [41]. 
 
While many studies have focused on the antimicrobial potential of nanoparticles through 
the catalysis of reactive oxygen species, it is also possible that nanoparticles participate directly 
in cellular redox processes, inducing oxidative stress more directly. A theoretical study 
conducted by Burello et al. surveyed a number of metal oxide nanoparticles, evaluating their 
conduction and valence band levels and comparing them to relevant physiological redox 
potentials [19]. Many of the evaluated metal oxide nanoparticles had theoretical conduction 
bands that overlapped with the range of physiological redox potentials, as shown in Figure 2.3. 
These nanoparticles may therefore be capable of abstracting electrons from biological 
compounds critical to cell regulation, which could unbalance the cellular redox state and lead to 
oxidative stress. 
 
Figure 2.3: The conduction and valence band levels of various metal oxide nanoparticles (measured on the absolute 




2.2.3 Metal Ion Dependent Pathways 
Metal nanoparticles have high surface energy, allowing them to solubilize and produce metal 
ions easily [42]. Heavy metal ions are known to be damaging to bacteria, and thus may represent 
a major component of nanoparticles toxicity. One study by Hachico et al. [43] examined the 
impact of silver ions released from silver nanoparticles on the membrane of P. putida, and found 
that relatively low concentrations of silver ions could prevent 100% of bacterial growth in 
comparison to control. The authors found that the ratio of cis to trans unsaturated fatty acids in 
the cell’s membrane was greatly increased with the increasing presence of silver ions. This 
conformational change from cis to trans isomers rapidly decreases membrane fluidity and 
permeability and is a common indicator of bacterial cell stress. 
Metal ions can also permeate the cells and cause damage to critical internal cellular 
components. In a study by Chatterjee and coworkers [44], DNA damage in the presence of 
copper nanoparticles was assessed, and it was found that within 30 minutes of contact time, the 
copper nanoparticles could completely convert super coiled DNA (the natural form of DNA) to 
Nick circular or linear confirmations, indicating extensive damage. To determine the source of 
damage, the authors also incubated the copper nanoparticles and DNA with reactive oxygen 
species scavengers or with ion chelators and found that only the copper ion chelator protected the 
DNA from extensive damage. Thus, the authors concluded that the release of ions from 
nanoparticles, not the generation of reactive oxygen species, was a primary driver in 
genotoxicity. Another study by Li and coworkers [30] explored the damage of heavy metal ions, 
and found that within 16 hours of exposure, the vast majority of metal ions localized in the cell’s 
mitochondria. The swelling of the mitochondria and loss of cristae suggested that the 




2.2.4 Influence of Surface Coatings on Antimicrobial Activity 
Some researchers have also proposed alternate pathways for the intracellular toxicity of metal 
nanoparticles. Sabella et al. conducted a study on the toxicity of a variety of metal nanoparticles, 
and concluded that the most important factor in predicting nanoparticle toxicity was the uptake 
of the nanoparticles into the cells through lysosome mediated endocytosis [45]. Two types of 
gold nanoparticles were studied in detail – one with a surface coating of 11-mercapto 
undecanesulfonic acid (MUS) and octanethiol (OT), and the other with a surface coating of MUS 
and 2,7-dimethyl octanethiol (brOT). The gold nanoparticles with the MUS and OT coating were 
shown to pass through the model cell membranes, whereas the particles with a MUS and brOT 
coating could only be internalized by the cell through endocytosis. The MUS and brOT particles 
that could only be internalized through endocytosis showed significantly higher toxicity, both in 
model cells and in an in vivo test with Drosophila melanogaster. It was proposed that when 
internalized in highly acidic lysosomes, the MUS and brOT gold nanoparticles were degraded, 
Figure 2.4: Difference in toxicity of metal nanoparticles depending on their internalization mechanism. Adapted 




causing a significant release of gold ions which could subsequently cause cell damage and death 
(shown schematically in Figure 2.4). In comparison, the MUS and OT coated nanoparticles which 
entered the cell’s neutral cytosol did not release cell-damaging ions.  
The role that proteins and other biomacromolecules that can adsorb to nanoparticle 
surfaces has also been investigated as a pathway that can modulate nanoparticle toxicity. Walkey 
and coauthors created a library of 105 different gold nanoparticles, with 3 different core sizes 
and 67 potential surface ligands that were subsequently attached [46]. The nanoparticles were 
each exposed to human serum, and the protein corona that adsorbed to each nanoparticle was 
quantified. Following serum exposure, the nanoparticles were inoculated into eukaryotic cell 
type cultures (A549 human lung epithelial carcinoma cells), and cell association of the 
nanoparticles was quantified. The adsorbed protein fingerprint, which was unique to each type of 
nanoparticle, was found to be a significantly better predictor of cell association than any other 
predictor tested, including nanoparticle size or surface charge alone. It is also of note that in 
general, smaller nanoparticles were found to have a higher protein corona density, which could 
theoretically amplify the type of interaction it has with a cell. 
While the previously proposed endocytosis mediated pathways only apply to eukaryotic 
cells, it is not a stretch to imagine that nanoparticle surface-adsorbed biomacromolecules would 
also affect the nanoparticle interactions with bacteria. A study by Jain and coauthors looked at 
the difference in antibacterial efficacy of silver nanoparticles with either bare surfaces, or with 
protein capping derived from fungal cells [47]. In general, the authors found that bare 
nanoparticles were much more effective at damaging the bacteria than the nanoparticles with a 
cocktail of proteins adsorbed to the surface. Bare surface nanoparticles were found to release 




intracellular ROS generation in all bacterial species tested. Another study by Li et al. observed 
similar results when testing the antibacterial capacity of iron nanoparticles with either bare 
surfaces or coatings of polymer or natural organic material (much like the nanoparticles would 
encounter in vivo or in the environment) [48]. The bare surface iron nanoparticles were 20 to 100 
times more effective at suppressing bacterial growth than any coated nanomaterial studied. When 
examined using transmission electron microscopy, the authors found that the bare iron 
nanoparticles were able to adsorb to the surface of E. coli cells, whereas any coating prohibited 
this interaction. The authors concluded that electrostatic or steric repulsion caused by the 
nanoparticle surface coatings prevented direct interaction of the nanoparticles with the bacteria, 
thus significantly lessening their bactericidal ability.  
2.3 Metal Nanoparticle Synthesis 
2.3.1 Single Metal Nanoparticle Synthesis 
Metal nanoparticles, as with most nanomaterials, can be synthesized with a wide variety of 
processes that can generally be divided into top-down and bottom-up processes. Top-down 
processes involve the breakdown of a bulk material into nanoparticles, most often through 
physical or chemical means. Bottom-up processes, in contrast, build nanoparticles up from 
smaller blocks, most often singular molecules. This includes processes such as chemical [49], 
[50] or electrochemical reduction [51]–[53] or radiolysis [54], [55]. Bottom-up processes have 
the advantage of providing more precise control over the composition and morphology of the 
generated nanoparticles and are often employed for the generation of metal nanoparticles in 
particular. 
Chemical reduction remains a very common method of synthesis for the production of 
nanoparticles. Colloidal solutions of metal nanoparticles have existed since antiquity [56], but 




used a boiling solution of sodium citrate to generate monodisperse gold nanoparticles. To 
generate metal nanoparticles using chemical reduction, three major components are needed: a 
metal precursor (often a metal salt such as AgNO3 or HAuCl), a reducing agent, and a capping 
agent [49], though in many cases one molecule can serve as both the reducing and capping agent. 
This process is represented schematically in Figure 2.5. Using chemical reduction, 
physiochemical properties such as nanoparticle shape and size, polydispersity, surface charge, 
surface free energy, and crystallization (ie exposed crystalline face) can be controlled [58]. This 
flexibility positions chemical reduction as an advantageous choice of fabrication method. 
 
Extensive work has been undertaken to identify ways of controlling the final morphology 
of metal nanoparticles synthesized by chemical reduction. Recent work by Vreeland and 
coworkers [59] showed that precise shape and size control could be achieved by controlling the 
amount and addition time of a metal precursor (As shown in Figure 2.6). The authors proposed 
that in classical nanoparticle synthesis, the concentration of unreacted monomer (metal salt 
precursor) increases until it reaches supersaturation, after which it is thermodynamically 
favorable to form nuclei. The formation of nuclei reduces the concentration of the monomer, and 
from that point onward the largest particles grow larger and the smaller ones dissolve. However, 
by adding additional unreacted monomer after the ‘burst’ nucleation phase, the particles can 
Figure 2.5: Schematic representation of the critical components for chemical reduction synthesis of metal 




achieve an extended steady-state growth phase, where the size increases continually and 
uniformly until no more monomer is added. In this way, the simple supplementation of metal salt 
precursor over a steady period of time allows for precisely controlled and reproducibly sized 
nanoparticles to be grown. 
 
Other work has shown that factors such as choice of reducing or capping agent can vastly 
alter the final shape of a generated metal nanoparticle. A study by Yao et al. [60] showed that 
platinum nanoparticles could take either an extended wire form or a spherical form, when either 
a weak reducing agent (such as ethylene glycol) or a strong reducing agent (citric acid) is used. 
The authors proposed that a strong reducing agent like citric acid would force all the metal 
precursor to reduce to a zero-valent state, and these atoms will then preferentially aggregate and 
form spherical nanoparticles. In contrast, the weaker reducing agent complexed with the metal 
ions without reducing them fully, allowing them to polymerize into wires prior to complete 
Figure 2.6: Growth of highly monodisperse magnetite nanoparticles over time using an ‘extended’ LaMer 




reduction. In another study [61], hexadecyltrimethylammonium bromide  (CTAB), a commonly 
used surfactant, was used to control the growth of gold nanoparticles into rods or plates rather 
than spheres. The selective adsorption of CTAB molecules onto {111} planes of gold 
nanoparticles blocks the further addition of gold ions in those locations, which promotes the 
observed anisotropic growth. 
2.3.2 Bimetallic Nanoparticle Synthesis 
The production of bimetallic and multimetallic systems has also been an area of growing interest 
in the past decades, particularly for application in the area of catalysis [62]. Bimetallic metal 
nanoparticles may be core/shell particles, where one metal tends entirely to the core and is coated 
with a ‘shell’ of the second metal, or they may form ‘ordered’ or ‘true’ alloyed structures, in 
which molecules of each metal are well or homogenously dispersed within the particle [63]. Less 
commonly, ‘Janus’ or ‘twinned’ bimetallic nanoparticles can be formed, where each metal is 
segregated in one area but still contacting the other on at least one face [64]. There are a variety 
of synthesis strategies for producing bimetallic nanoparticles, ranging from simple chemical 
reduction-like methods to more complex ones. 
Chemical coreduction is one of the simplest methods that can be employed to generate 
bimetallic nanoparticles, and generally involves a simple simultaneous chemical reduction with 
more than one metal precursor. In chemical co-reduction processes, the metal salt precusors for 
multiple metals can be mixed together, and reduction occurs simultaneously to form multimetal 
particles. The affinity and strength of the reducing or capping agents used towards each metal 
plays a large role in dictating the final morphology of the bimetallic structure. Work by Kuai and 
coworkers [65], for example, showed that gold/palladium particles could be formed with either a 
core-shell or a true alloy morphology depending on the reducing agent used. When 




core and palladium(II) was reduced second to form a core, because the reduction of gold is 
thermodynamically easier . In contrast, when CTAB (a strong reducing agent under 
hydrothermal conditions) was used, both gold and palladium could be reduced simultaneously, 
forming an alloyed particle (represented schematically in Figure 2.7A). Another study by Han et 
al. [66] showed that the morphology of gold/palladium particles could be changed gradually 
from quasi-spherical particles to flower-like structures simply by increasing the concentration of 
sodium citrate used (Figure 2.7B).  
 
Another relatively facile method for the generation of bimetallic structures employs 
galvanic displacement. This process relies on a two-step method – first, metal nanoparticles 
‘seeds’ are generated with one metal salt precursor, and then these seeds are exposed to a second 
metal salt precursor, often in the presence of additional reducing agents [67]. This process relies 
on ions of the second metal, which must be a metal of higher reduction potential than the seed 
material, to solubilize and replace the core metal, effectively etching parts of the core away and 
Figure 2.7 TEM image and formation schematic of gold/palladium bimetallic particles formed with PVP and CTAB 
as reducing agents (A), TEM images of gold/palladium bimetallic particles formed with increasing concentrations 




depositing the secondary metal. Galvanic displacement has been used to fabricate a wide range 
of particles, including silver/copper [68], silver/gold [67], and gold/palladium particles [69].  
2.3.3 Green Nanoparticle Synthesis 
The synthesis of metal nanoparticles using green, or environmentally sustainable, methods has 
grown greatly in the past years. A multitude of green fabrication strategies have been developed 
for metal nanoparticle synthesis, primarily based either on synthesis using single-cell cultures or 
synthesis using plant components (illustrated in Figure 2.8). Cellular synthesis most commonly 
leverages either whole cell culture, or cell-free supernatant (containing biomacromolecules 
produced by the cells) for synthesis. In whole cell synthesis, a metal precursor is introduced into 
a culture of living cells (either bacteria, algae, or some yeasts), and metal nanoparticles are 
generated within the cells themselves [70]. It has been proposed that the intracellular synthesis of 
nanoparticles is a byproduct of the cells’ inherent heavy-metal defense systems. The metal ions 
which enter the cells are sequestered, often either in the cell wall or within vacuoles in the cell, 
and then reduced as a strategy to mitigate their toxicity. As a result, the zero-valent ions in close 
proximity to one another are able to nucleate and form nanoparticles, similar to a chemical 
reduction strategy. Extracellular synthesis, on the other hand, utilizes biomacromolecules 
commonly produced by cells as reducing and capping agents, removing the cells from the 
solution prior to the start of the reaction [71]. In this case, nanoparticles are thought to be 
generated through simple chemical reduction pathways, where secondary metabolites produced 





Plant-based synthesis is the other common route of biological synthesis, and may involve 
the use of whole plant extract [73], or extract from specific components of a plant, such as the 
roots [74], leaves [75], or bark [76]. Most commonly, the plant matter is boiled in distilled or 
deionized water to extract phytochemicals, which can then be used directly in the synthesis of 
metal nanoparticles. Terpenoids and plant polyphenols are most commonly cited as playing a 
major role in the reduction and capping of metal nanoparticles, though organic acids and proteins 
may also contribute.  
 
Terpenes are cyclic or chained hydrocarbons built from isoprene units, and are considered the 
largest class of secondary metabolites found in nature [77]. Many plant-derived terpenoids 
contain functional moieties such as carboxylic acid or hydroxyl groups, which play a key role in 
Figure 2.8: Methods of biological synthesis for metal nanoparticles. 
Figure 2.9: Common types of plant derived terpenes, and their role in the reduction and capping of metal 




the reduction of metal ions to zero-valent atoms (as shown in Figure 2.9) [78]. For example, work 
by Dubey et al. [79] showed that extract of Tansy fruit could easily form silver or gold 
nanoparticles, which was attributed to reduction of the metal salt precursors by terpenoids found 
in the essential oil extract. The authors proposed specifically that the terpenoids containing a 
carbonyl group could undergo conversion from =C=O to –C(O)=O, providing the necessary 
electron for reduction. 
Plant polyphenols are another major class of biomolecules that participate in the synthesis 
of metal nanoparticles. These molecules all contain a hydroxy-substituted benzene ring in their 
structure, and can range from very simple to very complex. As of 2015, over eight thousand 
types of polyphenols had been identified [80]. Singh and workers showed that clove extract 
could be used to successfully synthesize both gold and silver nanoparticles [81], which contains 
a high concentration of the polyphenol eugenol. The reaction scheme, shown in Figure 2.10A, 
shows that when eugenol is deprotonated, it can either exist in a resonance stabilized form, or 
oxidize and expel 2 electrons. These two electrons can then participate in the reduction of either 
two Ag+ ions or half an Au4+ ion. A study by Liu et al. showed that polyphenolic compounds 
from rice husk extract could be used to synthesize silver nanoparticles [82]. Caffeic acid (CA), a 
Figure 2.10: Reaction schematic for the reduction of metal nanoparticles by eugenol (A) or caffeic acid (B). 




polyphenolic acid, was proposed to play a major role in the reduction, as one molecule of CA is 
able to donate up to 5 electrons to a metal precursor (Figure 2.10B).  
 
2.3.4 Green Synthesis Using Biopolymers 
Synthesis of metal nanoparticles using naturally derived biopolymers is a specific area of 
interest, as many biopolymers provide a combination of reducing or capping capabilities, and 
improved colloidal stability. Work has been done to generate nanoparticles using polymers such 
as chitosan, alginate, and cellulose [83]–[86]. Nanoparticles generated using cellulose 
nanocrystals (CNC) are of particular interest, as CNC has useful properties including high 
thermal stability, high mechanical strength, and low cytotoxicity [87]. Additionally, cellulose is 
considered the most abundant biopolymer on earth, and pristine nanocellulose can be 
biodegraded in a span of just weeks [88]. CNC has been used extensively as a capping agent in 
the synthesis of metal nanoparticles, and has been shown to promote the generation of 
monodisperse and stable colloids [89]. Lokanathan and colleagues explored the impact of 
increasing concentrations of CNC on the formation of silver nanoparticles [90], and found that a 
higher concentration of CNC generated significantly smaller nanoparticles (shown in Figure 
2.11). The authors proposed that the hydroxyl groups on the surface of the CNC play a role in 
coordinating the metal ions, causing the deposition of the nanoparticles directly on the surface. 
An increase in CNC concentration increases the number of potential nucleation sites, therefore 
generating more, smaller nanoparticles. Additionally, the sulfate half ester groups, present on the 
surface of cellulose nanocrystals generated via sulfuric acid hydrolysis, play a role in the capping 




Recent work has also shown that cellulose nanocrystals can be used for ‘reductant-free’ 
synthesis of metal nanoparticles, in which the cellulose acts as both the reducing and capping 
agent. Reductant free synthesis has been achieved either under hydrothermal synthesis conditions 
[91] or using chemical reduction in a highly basic environment [92]. In both cases, the reduction 
of the metal salt precursor to a nanoparticle was attributed to the hydroxyl groups present on 
CNC’s surface. At high enough temperature or in highly basic conditions, the hydroxyl groups 
become deprotonated, exposing an electron-rich oxygen anion that can participate in redox 
reactions. Additionally, the exposed oxygen may be capable of anchoring the metal nanoparticles 
to the CNC surface through electrostatic interactions [93]. Given the ability of CNC to act as 
both a reducing and capping agent, and its superior physical properties and sustainability, it is a 
promising choice for use in the synthesis of metal nanoparticles for a wide range of applications. 
(d) 
Figure 2.11: TEM images of silver nanoparticles generated with 0.1 wt% (a), 0.25 wt% (b), or 0.5 wt% (c) cellulose 
nanocrystal solutions as the capping agent. Scale bars represent 100 nm. Range of silver nanoparticles sizes for 





A narrow summary of the literature on the fabrication and antimicrobial activity of nanoparticles 
has been presented in this section. While much work has attempted to determine how metal 
nanoparticles suppress or kill bacteria, there exists no field-wide consensus on the most 
important or true mechanisms. A lack of mechanistic understanding makes it challenging to 
understand which physiochemical parameters make metal nanoparticles maximally effective. 
More work therefore remains to be done in the generation of nanoparticles with specifically 
targeted physiochemical characteristics ideal for use in antimicrobial applications. The synthesis 
of metal nanoparticles using cost effective and eco-friendly methods has also been highlighted. 
Biopolymers, and particularly cellulose nanocrystals, show promise for use in the generation of 
controlled metal nanoparticles. CNC-capped silver nanoparticles have been successfully 
generated through a variety of methods, and more work remains to be done on the synthesis of 
other metal nanoparticles using CNC. This thesis work aims to contribute to the fabrication of 
maximally antimicrobial and sustainable metal nanoparticles both by furthering the mechanistic 
understanding of antimicrobial nanoparticles using data mining and meta-analysis, and by 
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Within the last century, antibiotics have become the primary treatment for harmful bacterial 
infections. Most antibiotics are developed by exploiting the natural ability of specific bacteria to 
produce secondary metabolites that play a role in defending against competing microbes [94]. 
These compounds are identified and isolated from the bacteria based on their toxicity towards 
select human-infecting microorganisms, and then reproduced on the mass-scale as antibiotics to 
combat infection. Because antibiotic chemicals are synthesized by bacteria themselves, small 
portions of bacterial populations may naturally evolve to contain mutations that result in 
antibiotic resistance. In recent years, high rates of antibiotic use have allowed the propagation of 
resistant strains, some of which are virtually untreatable with currently developed antibiotics 
[95]. In response to this crisis, ways to manage and mitigate bacterial infection are being 
developed. 
Metal nanoparticles (MNPs) are well known to be antimicrobial, and could play a major 
role in addressing drug resistant infections. MNPs have already been extensively investigated for 
their antibacterial properties, with nearly 14,000 publications on the subject in 2019 alone. 
Additionally, numerous reviews have been compiled to distill the vast body of literature on the 
efficacy of MNPs [96]–[98]. There is a myriad of pathways through which MNPs are proposed 
to exert cellular toxicity, though there remains no consensus on which pathways are most true or 
most important. Until the activity of MNPs is better understood, it will be very challenging to 
design optimally bactericidal MNPs, limiting the scope of their clinical application. 
While there is yet to be agreement on a singular bactericidal mode of action, there are a 
number of widely referenced hypotheses. One commonly cited mechanism suggests that there 
are electrostatic interactions between positively charged metal ions and the negatively charged 




bacterial cells may damage the phospholipid bilayer of Gram negative bacteria [101] or the 
peptidoglycan layer of Gram positive bacteria [36]. Negatively charged metal nanoparticles may 
also be attracted to positive residues found in many bacterial membrane proteins [35], and MNPs 
adsorbed to bacteria have been shown to induce pits in the membrane, indicating severe damage 
[31], [32]. 
Another hypothesis is that metal ions leached from nanoparticles can infiltrate bacterial 
cells and cause damage to integral proteins or organelles within the cell. Silver ions have been 
shown to chelate sulfur-containing or phosphorous-containing compounds such as DNA, 
preventing cell replication [35]. Likewise, copper ions have been found to significantly damage 
or destroy bacterial DNA [44]. In addition to direct damage caused by chelation, released metal 
ions (as well as MNPs themselves) can generate reactive oxygen species (ROS), which induce 
oxidative stress and eventual apoptosis [102]. 
All proposed routes of MNP toxicity depend heavily on the nanoparticle’s specific 
physiochemical properties, such as metal type, size, surface charge, and attached surface ligands. 
MNP size and exposed crystalline face are known to affect catalytic activity, dictating which 
ROS byproducts are produced [103], [104]. The surface charge of MNPs also dictates their 
colloidal stability, preventing agglomeration and helping nanoparticles retain high specific 
surface area [105]. This in turn may affect the catalytic behavior of the nanoparticles and the 
magnitude of ion dissolution from their surface [106]. 
Some studies have sought to correlate fundamental physiochemical characteristics of 
MNPs, such as size or surface charge, with their antimicrobial performance [35], [107], [108]. 
However, there are so many permutations of metal type, size, charge, capping agent, and post 




physiochemical characteristic dominates the response. Only a few studies have attempted to 
create a library of nanoparticles and understand their biological activity, and those have focused 
solely on the effects of MNPs on eukaryotic cell lines, not bacteria [46]. 
In addition to the challenge posed by the vast variance in physiochemical properties that 
may influence MNP’s antimicrobial activity, the cross comparability of individual MNP studies 
is low due to a lack of standardization in the testing of the MNPs. There are several common in 
vitro testing methods for evaluating antimicrobial efficacy, including broth dilution tests, such as 
minimum inhibitory concentration (MIC) or minimum bactericidal concentration (MBC), and 
zone of inhibition (ZOI) tests, such as disk diffusion or well diffusion [109]. While these tests are 
often assumed to be comparable in evaluating the overall performance of MNPs, broth MIC and 
MBC tests measure the dilution (or dose) of the MNPs, whereas ZOI tests measure the diffusion 
of the MNPs, rendering them incomparable. 
The actual interaction of the MNPs with the testing method chosen also must be 
considered before comparability can be assumed. In ZOI tests, if a compound being tested has 
poor solubility in the chosen agar, the test may incorrectly show low or no efficacy [110], [111]. 
ZOI tests were developed for antibiotic molecules, which can be an order of magnitude smaller 
than MNPs. Most nanoparticles have comparatively low diffusivity in the ZOI tests, and only 
soluble ions that are released from the nanoparticles will be able to participate in antibacterial 
activity. Dilution techniques such as MIC and MBC are therefore generally considered more 
robust, but the specific assay set-up can still influence the measured efficacy of MNPs. The 
chosen incubation broth, initial inoculum size, and specific strain of the bacterial model have all 




The massive heterogeneity in the literature on metal nanoparticles makes it incredibly 
challenging to identify real trends in what makes a nanoparticle an effective antimicrobial agent. 
To determine what MNP properties are likely influential, we employ a meta-analytical technique, 
which is a process that systematically combines the results of hundreds of studies and allows for 
significantly increased statistical explanatory power. Meta-analysis has very recently been used 
to predict the interactions of select nanomaterials with eukaryotic models [115], [116], but to the 
best of our knowledge, no one has undertaken this work with antibacterial MNPs. The goal of 
this meta-analysis is therefore two-fold: to determine how well standardized the field currently is 
(in essence, to understand the cross comparability of the knowledge that has been generated), and 
to identify statistically robust trends around the influential physiochemical properties of 
antimicrobial MNPs. This in-depth analysis may also provide a starting point to make the case 
for the necessity of standardization in antimicrobial MNP testing. 
3.2. Experimental Procedure 
3.2.1 Initial article collection 
Peer reviewed original articles on antimicrobial metal nanoparticles published between January 
2015 and January 2019 were collected from Web of Science using advanced topic search. For each 
of the four metals of interest (silver, copper, gold, and zinc), a search was performed to find articles 
whose topics included reference to both a metal nanoparticle and antimicrobial activity. Variance 
in reporting language was accounted for in the search by including multiple potential search terms 
for each topic (searching antibacterial OR antimicrobial, silver OR Ag). In total, the initial search 
yielded 9252 articles across the four metals, which were further assessed for inclusion in the 





3.2.2 Dataset refinement and inclusion criteria 
All identified articles were screened for relevance and reliability before being included in the 
meta-analysis, as detailed in Scheme 1. The systematic screening process followed methods 
previous laid out for use in meta-analysis [117]. Following initial article identification, the author 
defined keywords of all articles were compiled and assessed for mention of both metal 
nanoparticle(s) and antimicrobial activity. Of the original 9252 potential articles identified, 2907 
contained keywords relating both to metal nanoparticle(s) and antimicrobial activity. These 2907 
articles were then manually screened for relevance to the meta-analysis. Publications were 
considered relevant if they (1) reported on a single, unmodified metal nanoparticle (i.e. not 
multimetallic, not loaded with additional antimicrobial agents, not incorporated into a 
composite), and (2) included a quantitative assessment of the antimicrobial performance of said 
nanoparticle. Only articles that utilized a minimum inhibitory concentration (MIC) assay were 
considered eligible for use in the quantitative analysis, to minimize heterogeneity and allow for 
reasonable cross-comparison between articles. The 113 articles [33], [106], [110], [111], [117 – 
221]  To prepare the data for analysis, each article was divided into individual records containing 
one nanoparticle evaluated against one strain of bacteria. Articles yielded between 1 and 18 
records each, with modal value of 4 records per article, for a total of 398 records. 




All articles that were included in the qualitative analysis were manually assessed, and 
data was extracted on both physiochemical characteristics of the nanoparticle and testing 
parameters for antimicrobial performance. A total of 15 variables – 6 continuous and 9 
categorical – were documented for each article mined.  The physiochemical properties noted 
were nanoparticle type (silver, copper, gold, or zinc), capping agent used during synthesis 
(grouped into either plant extract, cell culture extract, or others), nanoparticle size (in nm) as well 
as the size evaluation method (TEM, DLS, or others), nanoparticle shape, and nanoparticle 
surface charge as measured by zeta potential (in mV). For the MIC assay parameters, broth 
formulation (Mueller Hinton, Nutrient Broth, Luria Bertani, Tryptic Soy, or others), incubation 
time and temperature (in h and ˚C respectively), inoculum size (in colony forming units per mL), 
and nanoparticle minimum inhibitory concentration (in number of particles per mL) were 
catalogued. Lastly, information on the bacterial species, Gram type, and specific strain was 
collected. 
In addition to raw data, grouping variables were added to improve comprehension and 
allow for the identification of overall trends. These grouping variables included capping agent type 
(divided simply into plant-based synthesis, cell culture-based synthesis, and others) and the gram 
type of the bacteria. An ‘unknown’ designation was given for any single category not reported 
within a paper. The units for numeric categories of size, zeta potential, MIC, time, temperature, 
and inoculum size were standardized to nm, mV, µq/mL, h, ˚C, and number of colony forming 
units (# CFU) respectively. CFU values were additionally normalized using the natural log 





3.2.3 Statistical analysis 
All statistical analysis was performed using Systat 13. Simple descriptive statistics were used to 
understand the trends in information reported, including the range of continuous variables and the 
frequency with which each variable was reported. ANOVA testing was used to determine 
differences in mean values for cross-comparative analysis and was performed for any population 
with greater than 5 records. ANOVA results were considered significant when p < 0.05. Linear 
regression was used to correlate physiochemical parameters with antibacterial efficacy. For data 
quality control during the building of regression models, any records with standardized residuals 
of  > 5  were considered outliers and discarded, after which regressions were recalculated. This 
process continued iteratively until no outliers remained. All regression fits were linear, with 95% 
confidence bounds. Regression results (slope fit) were considered statistically significant when p 
< 0.05.  
3.3 Results and Discussion 
3.3.1 Literature search & data extraction.  
Original research articles published over a four-year span on silver, copper, gold, or zinc 
antimicrobial metal nanoparticles (MNPs) were identified using the Thomson Reuters Web of 
Science database. 9252 articles were initially identified as potentially relevant (see Methods), the 
majority of which (73%) reported on silver nanoparticles, followed by those that reported on zinc 
(14%), gold (7%), and copper (6%) MNPs. The texts were assessed to determine the antibacterial 
assay used. A majority of the papers initially identified from the literature (60%) used some form 
of ZOI test, such as disk or well diffusion, while only 20% of the articles reported an MIC test. A 
small minority of studies used more qualitative methods such as growth kinetics (4%) or plate 
streaking (3%) as their primary method of evaluation, and singular papers assessed antimicrobial 




respiration quantification. Zone of inhibition tests are likely the most common evaluation method 
due to their relative ease of use and comparatively low cost. However, ZOI tests are qualitative, 
not quantitative, so they cannot be directly used when trying to compare the relative efficacy of 
two separate studies [223]. Additionally, the solubility of the metal [111] in the chosen agar can 
drastically decrease or eliminate the measured inhibition zone of an otherwise antimicrobial 
MNP. Thus, only studies that employed an MIC test were included in the quantitative dataset. 
These articles were further assessed to determine reported information on the physiochemical 
characteristics of the MNPs fabricated, the MIC assay parameters used, and the bacterial models 
(reported in Figure 3.1).  
3.3.2 Trends in antimicrobial nanoparticle evaluation and reporting.  
While MIC broth dilution tests are considered to be more robust than ZOI tests, large variance in 
the specific methodological parameters used in individual studies was noted, which poses a 
significant barrier to rigorous cross-comparison of antimicrobial MNP studies. Standards for 
broth dilution methodologies have already been developed [224], but the adherence to these 
protocols is currently low in the field. Less than 8 percent of the articles considered in this study 
both provided a complete report on the utilized testing set-up and followed a standard protocol. 
Determining which studies are maximally cross-comparable is hindered by the vast number of 
reports that do not provide full and complete details on the nanoparticle synthesized, the 
experimental set-up used, or the model organism(s) tested. Only 27.75% of the articles 
considered in this study reported all 15 variables of interest, while 35.85% were missing one 
value, 23.58% were missing two values, and 19.81% were missing three or more values. The 
most commonly underreported variables were the surface charge of the synthesized nanoparticle 
(measured with zeta potential or otherwise), the number of colony forming units in the initial 




commonly unreported factors have been shown to affect the observed antimicrobial efficacy 
[112], [113], [225], suggesting that without report of these factors, it is impossible to understand 
the true behavior of a nanoparticle studied.  
Going forward, a standardized characterization and reporting protocol is suggested to 
ensure studies are similar enough for meaningful cross comparison. At minimum, nanoparticle 
material characteristics including the metal type, nanoparticle size, nanoparticle shape, capping 
agent used, and surface charge should be reported. The testing environment parameters, 
including the broth type used, the initial bacterial inoculum size, the time and temperature of 
incubation, and the concentration(s) of nanoparticles tested should also be reported. Lastly, the 
Figure 3.1: Summary of information on nanoparticle’s physiochemical characteristics, antibacterial assay 
used, and bacterial models tested for publications included in the quantitative dataset. For categorical 
variables (1-2, 4-5, 7-8, & 13-15), the total number of categories for that variable is bolded, and the percent of 
the population belonging to the most frequent categories are provided (*n/a for assay type, which encompasses 
all publications mined). For all continuous variables (3, 6, 9-12), the complete range as pulled from the 




species and specific strain of the bacteria tested for susceptibility should be considered and 
reported. 
3.3.3 Cross-comparative analysis of silver, copper, gold, and zinc antimicrobial 
MNPs.  
For all metal types, the three most commonly used model bacteria were E. coli, S. aureus, and P. 
aeruginosa, representing 33.1%, 28.6%, and 19.1% of the overall records respectively. E. coli is 
frequently used as a model Gram-negative bacterium, and S. aureus holds the same status for 
Gram-positive bacteria. P. aeruginosa, another Gram-negative bacteria, is a clinically relevant 
target for nanoparticle therapy, as this bacteria is naturally highly drug resistant [226], [227]. 
 
The variance in MIC values derived from the literature was high for all four metal types, 
irrespective of the bacterial species used as a model. The average MIC value for silver MNPs in 
this study did not differ significantly from the average MICs of copper or gold MNPs (p >> 
0.05), but it is not possible to determine from simple aggregate analysis whether the lack of 
significant difference in MIC between silver, copper, and gold is because metal type is not a 
driving factor in antimicrobial activity, or because of confounding factors adding noise to the 
system. Zinc MNPs, in contrast to copper and gold, were found to have a statistically 
significantly higher average MIC value than silver for all bacterial species tested (p < 0.01), 
Table 3.1: Average minimum inhibitory concentration (in µg/mL) for four highly reported types of metal 
nanoparticles and two broad spectrum antibiotics. * signifies the value is significantly different from silver for the 
same bacterium, p < 0.01.  
** signifies the values is significantly different from silver for the same bacterium, p < 0.001. n/a indicates too few 




despite the high levels of variance in the datasets. Zinc can therefore be concluded to be a less 
effective antimicrobial material than silver. 
While silver nanoparticles do display the lowest average MIC value, a significant 
difference in performance of silver MNPs when compared to traditionally used antibiotics was 
found, as seen in Table 1 (p < .001). Ciprofloxacin and imipenem, two broad-spectrum 
medications belonging to two different classes of antibiotics (quinolone antibiotics and 
carbapenem antibiotics respectively), have reported MIC values that often fall well below 1 
µg/mL, depending on bacterial species and strain tested [228]–[241].  Further improvement to 
the antimicrobial efficacy of MNPs on a per mass basis will be an important milestone in 
achieving medically translatable antimicrobial treatments using MNPs. 
 
3.3.4 Determining influential physiochemical characteristics of silver MNPs.  
Physiochemical parameters such as MNP size and surface charge have previously been proposed 
to influence the antimicrobial efficacy of a nanoparticle. However, the very disparate nature of 
individual MNPs that have been fabricated and tested makes it challenging to draw reliable proof 
from the literature. To increase the explanatory power of the work that has been done, this study 
sought to evaluate the effect of physical parameters on antimicrobial activity (as measured with 
minimum inhibitory concentrations) from a meta-analytical standpoint. Studies were considered 
as singular records of a physiochemical parameter and an MIC value, and the aggregate data 
from multiple articles was analyzed using linear regression techniques. 
As regression techniques are more reliable and more effective with larger bodies of data, 
regression analysis was only performed using data on silver MNPs that were tested against E. 
coli or S. aureus models of any strain, as these combinations of metal type and bacterial model 




equally valuable, so to control for assumed rigor, only the papers that reported all 14 
experimental variables (those described in Fig. 1) were included. With all these considerations, 
57 records were included in the initial dataset. Prior to final analysis, data quality control was 
performed, and any record with a reported MIC value that lay 3 standard deviations or more 
away from the mean, or with a residual value greater than 5 in a simple one variable regression 
model, were considered outliers and removed. This process was repeated iteratively until there 
were no outliers, leaving a final set of 48 records on antimicrobial silver nanoparticles to be 
analyzed. It is worth noting that the data set for regression analysis naturally contained a much 
more normal and homogenous group of studies than the total set originally mined from the 
literature. The range of MIC values in the final set was 10 to 58 µg/mL, the range of surface 
charge (zeta potential) values was -58 to -10.5 mV, and the range of MNP size values was 0.78 
to 32 nm in diameter. 
Nanoparticle size had a significant effect (p <.0001) on the measured MIC for E. coli. As 
seen in Fig. 2A, there is a positive relationship between size and minimum inhibitory 
concentration, demonstrating that smaller nanoparticles are more effective against E. coli, and 
potentially against Gram-negative bacteria at large. The measured R2 value of 40.3% shows that 
despite the heterogeneity of the specific MNPs included in the analysis, over 40% of the variance 
in results is driven exclusively by nanoparticle size. 96.2% of the observed data points fell within 
the prediction limits of the size-only model, showing very good agreement between the model 
and the literature-derived values. In stark contrast to this result, nanoparticle size was not a 




Nanoparticle size has previously been proposed as a driving factor in determining MNP 
antimicrobial activity, with the assumption that smaller nanoparticles are broadly more effective 
against all types of bacteria.  A number of studies [242], [243] have suggested that the MNPs 
must be below a critical size (for example, 10 nm in diameter) to cross a bacterial cell membrane 
and damage the cell directly. MNP size has also been shown to modulate the interaction of the 
nanoparticle with biological molecules. It has also been shown that for very small MNPs, 
complex protein adsorption occurs almost instantly in in vivo like conditions [244], and the 
proteins adsorbed change the extent of the nanoparticle/bacterial interaction [245]. However, 
very little previous work exploring the relationship between nanoparticle size and antimicrobial 
Figure 3.2: Linear regression models correlating antibacterial efficacy, as measured by minimum inhibitory 
concentration, with nanoparticle size (A and C) and surface charge (B and D). Black dotted lines represent regression 
lines of best fit, dashed colored lines represent upper and lower confidence intervals (95% confidence), and solid 
colored lines represent upper and lower prediction intervals. Models highlighted in green where a statistically 




efficacy has considered the effect of Gram type as a driving factor. The aggregate data from this 
study clarifies the linear correlation of MNP size with MIC when tested against E. coli, but not S. 
aureus, indicating that a physiochemical characterization alone is not sufficient to describe how 
size influences the antibacterial efficacy. Rather, the specific characteristics of the bacteria, most 
notably the Gram type, play a simultaneous role. 
The effect of MNP surface charge was also explored with a single variable regression. 
For E. coli, no statistically significant trend was observed, suggesting that surface charge does 
not dictate the effect of MNPs when used against Gram-negative bacteria. However, a very 
strong linear dependence was shown for S. aureus (p < .005), where more negatively charged 
particles are much more effective than less negatively charged particles. The model fit (R2) was 
found to be 30.1%, indicating that a third of the variability in MNP efficacy can be explained 
singularly by surface charge. It is of note that the dataset did not include any MNPs with a 
positive surface charge, so it is not possible to determine from this model whether the greater 
effect of more negatively charged particles is due to the increasing negativity or the increasing 
magnitude of charge.  
As with size, surface charge has previously been proposed to affect the activity of 
nanoparticles against bacteria. When comparing nanoparticles with zeta potentials that are highly 
positive or highly negative, the more positively charged nanoparticles are found to be most 
effective. It is commonly proposed that the increased efficacy of positively charged particles is 
due to the stronger electrostatic interactions between the particles and the negatively charged 
bacterial cells. However, very little research has been done on the effect of magnitude of charge, 
particularly in negatively charged particles, despite the fact that most metal nanoparticles are 




charge on the Gram selectivity of nanoparticles has only recently been explored, and only for 
mixed or positively charged nanoparticles [108]. 
In addition to singularly looking at size and surface charge regression, multivariate 
models were built to explore the interaction between these parameters. An additive model of size 
and surface charge was built, effectively allowing each parameter to be understood while the 
other was controlled for. The additive model of size and surface charge did not differ in 
significance or fit from the size model for E. coli, increasing the evidence that size is the most 
important physiochemical parameter for Gram-negative bacteria. However, the additive model 
for S. aureus had an improved R2 of 44.6%, up almost 15% from the single variable surface 
charge model. Additionally, in the additive model, both size and surface charge were statistically 
significant (p < 0.05 and p < 0.001 respectively). This suggests that while surface charge does 
dominate the response, size may also play a smaller but significant role for MNPs used against 
Gram-positive bacteria. 
3.4 Conclusions 
Meta-analysis was performed on data mined from the literature over a five-year span to 
determine the trends in testing and reporting on antimicrobial metal nanoparticles. Simple 
aggregate analysis shows that silver nanoparticles are statistically more effective than zinc oxide 
nanoparticles at killing or suppressing both Gram-negative and Gram-positive bacteria, but that 
there is not a significant difference in the antimicrobial activity of copper or gold particles when 
compared to silver. It is not possible to determine whether metal type would emerge as a driving 
factor in antimicrobial activity when the heterogeneity in testing and reporting protocols is 




Nanoparticle size is a defining factor in predicting the antimicrobial activity of silver NPs 
against Gram-negative bacterium (p < 0.0001). The compiled papers indicate a positive 
correlation between size and MIC (R2 of 40.3%), where smaller MNPs are more effective and 
thus require lower concentrations to inhibit bacterial growth. In contrast, size alone is not shown 
to affect the MIC of silver NPs against Gram-positive bacteria. Differences in the cell wall and 
membrane structures of these bacteria may modulate the bactericidal mechanism(s) of MNPs.  
Surface charge does not show any significant correlation with MIC for Gram-negative bacteria. 
However, the efficacy of silver MNPs against Gram-positive bacteria is considerably affected by 
zeta potential (p < .005) where highly negative MNPs require lower concentrations to inhibit 
bacterial growth than less negative MNPs. Interestingly, multivariate regression using both size 
and surface charge as independent variables creates a more rigorous model (R2 of 44.6%), 
indicating that the antibacterial efficacy of MNPs against Gram positive bacteria is dominated by 
charge, but is also somewhat affected by the size of silver NP used. 
Due to the sheer number of papers that did not report significant material and testing 
parameters (such as surface charge, number of bacterial colony forming units used in the 
inoculum, and the specific bacterial strain tested), more intricate analysis is not possible. It is 
critical that common antimicrobial testing and reporting methods are adopted, to allow further 
insight on the exact mechanisms of MNP antimicrobial activity to be obtained. This study 
demonstrates that while improvement in standardization is needed, meta-analytical techniques 
can still be employed to successfully generate new knowledge by data-mining and analyzing the 




Chapter 4: Synthesis and 
Characterization of Copper-, Silver-, and 
Copper/Silver-Cellulose Nanocrystal 





The green synthesis of metal nanoparticles is very desirable to reduce cyto- and ecotoxicity and 
increase their range of applications. A large body of work on the synthesis of metal nanoparticles 
using living cells [246]–[248], cell culture extract [249]–[251], and plant extracts [252]–[254] 
has been generated in the past decades. Of particular interest is the fabrication of metal 
nanoparticles using cellulose nanocrystals as an ecofriendly substrate. Cellulose nanocrystals 
(CNC) can be derived from plant matter, bacteria, and tunicates, and have been shown to have no 
toxicity to human cells [255]. Additionally, they have desirable physical properties such as good 
dispersibility [256] and high mechanical strength [257]. CNC derived from acid-hydrolyzed 
wood pulp has been shown to be highly effective at coordinating nanoparticles [86], where the 
hydrolysis-generated sulfate half ester groups act participate in nanoparticle capping and the 
abundant hydroxyl groups participate in the capture of metal ions [90]. 
 Much work has been done on the preparation of cellulose nanocrystal-bound metal 
nanoparticles, for applications such as food packaging [258], [259], sensing [260], [261], water 
purification [262], and catalysis [89], [91]. Antimicrobial metal and CNC composites have also 
been developed through a variety of routes, including hydrothermal synthesis [263] and chemical 
reduction [264]. However, much of this work involves the use of toxic or environmentally 
harmful reducing agents, such as sodium borohydride [8], or non-biodegradable polymers, such 
as polyethylenimine [265]. This precludes these composites from being considered completely 
green and increases the risk of downstream cyto- or ecotoxicity.  
 The development of more sustainable metal/CNC composites has been recently explored, 
using natural compounds for both the reducing and capping of metal nanoparticles. Shi and 
coworkers [266] developed a silver and CNC composite by coating polydopamine, a mussel-




polydopamine were able to successfully coordinate with and reduce the silver ion precursor to 
silver nanoparticles, resulting in a multitude of well dispersed nanoparticles on the CNC surface.  
 While this is a relatively effective strategy, the polymerization of polydopamine from 
dopamine requires a significant time period, which limits the scalability of the product. In this 
work, a similar one-pot reduction method was employed, with tannic acid used as the CNC 
coating instead of dopamine. Tannic acid is a plant derived polyphenol, and has previously been 
used as a coating in biomedical applications due to its biodegradability and self-coating behavior 
[267]. Tannic acid has also been extensively used in the synthesis of metal nanoparticles, and can 
act as both a reducing and capping agent [268]. 
In this chapter, metal nanoparticles were deposited on tannic acid-coated cellulose 
nanocrystals using a simple one-pot chemical reduction method. The impact of fabrication 
parameters was explored, and the order of reagent addition was found to have a strong influence 
on the final morphology of the composite. The generated copper/CNC and silver/CNC 
composites had high colloidal stability, and the metal nanoparticles were found to be very small 
(<10 nm average in diameter), which indicates that they may be promising for antimicrobial 
application. Additionally, the same one-pot system can be used to reduce copper and silver onto 
CNC simultaneously, demonstrating a desirable versatility. 
4.2. Experimental Procedure 
4.2.1 Materials 
Cellulose nanocrystals, with length of 100 to 200 nm and width of 5 to 20 nm, were donated by 
CelluForce Inc. Tannic acid (C76H52O46) , silver nitrate (AgNO3), copper sulfate (CuSO4), and 
sodium hydroxide (NaOH) pellets were purchased from Sigma-Aldrich and used as received. 
Milli-Q water (resistance of greater than or equal to 18 MΩ cm) was used as the sole solvent for 




4.2.2 One Pot Preparation of Metal/CNC/Tannic Acid Composites 
Cellulose nanocrystals (CNC) were mixed into 15 mL of Milli-Q (MQ) water at a concentration 
of 0.01 wt% with a vortex mixer and thoroughly dispersed via bath sonication for 25 minutes at 
10˚C. Powdered tannic acid (0.255 g) was dispersed in 15 mL of MQ water (a concentration of 1 
mM) with vigorous shaking and vortex mixing. Stock solutions of metal salt precursors (either 
CuSO4, AgNO3, or an equal combination of the two) were dispersed in MQ water with vigorous 
shaking and vortex mixing. The CNC and tannic acid solutions were combined with vortex 
mixing, and then the pH of the CNC/tannic acid solution was adjusted to 9.0 used aliquots of 
freshly prepared 1.0 M NaOH solution. The CNC/tannic acid was then transferred to a round 
bottom flask and heated to 50˚C under stirring at 400 RPM. Metal salt precursor solution was 
added dropwise to the CNC/tannic acid solution to achieve a molar ratio of 0.06 (for copper) or 
0.03 (for silver or copper/silver), following the procedure for rapid generate of metal 
nanoparticles with tannic acid previously laid out [269]. The reaction began immediately, and 
was allowed to proceed for 4 hours at elevated temperature. The metal/CNC/tannic acid solution 
was then centrifuged at 4250 RPM for 30 minutes, and the supernatant was decanted. The pellet 
(containing the CNC-bound metal nanoparticles) was re-dispersed in fresh MQ water and stored 
for further use. 
 
4.2.3 Composite Characterization 
4.2.3.1 UV-Visible Spectra 
A UV-Visible Spectrometer was used to generate spectra from 200 to 800 nm. All samples were 
prepared in MQ water at a 0.1 wt% concentration, and bath sonicated for 2 minutes directly prior 
to measurement. Scans were performed at room temperature and latent pH. Each spectrum was 





4.2.3.2 Hydrodynamic Size and Zeta Potential 
Hydrodynamic size and zeta potential (ZP) were both determined using a Malvern Nano-ZS90 
Zetasizer. Samples were diluted to a 0.1 wt% (w/w) concentration in MQ water and bath 
sonicated for 2 minutes directly prior to measurement. Hydrodynamic size was determined using 
single angle (90˚) dynamic light scattering at room temperature. Zeta potential was determined 
based on electrophoretic mobility at room temperature. All measurements were taken 5 times and 
the average is presented. 
4.2.3.3 Transmission Electron Microscopy 
Samples were diluted to a concentration of 0.1 wt% (w/w) in MQ water and bath sonicated for 
30 minutes at 10˚C to assure dispersion. 25 µL of sample was drop-cast on a carbon-coated 
copper grid (200 mesh) and allowed to dry for 24 hours in ambient conditions. A Philips CM 10 
transmission electron microscope with a 60 kV accelerating voltage was used to take all images. 
All image analysis was performed using ImageJ software. Nanoparticle sizes derived from 
ImageJ software represent the average value no less than 100 particles. 
4.2.3.4 Scanning Electron Microscopy 
Samples were diluted to a concentration of 0.1 wt% (w/w) in MQ water and bath sonicated for 
30 minutes at 10˚C to assure dispersion. 25 µL of sample was drop-cast on a new silicon wafer 
chip and allowed to dry for 24 hours in ambient conditions. The wafer was coated in a thin layer 
of gold (thickness < 5 nm) using a simple sputter-coating process to improve conductivity of the 
samples. An FEI Quanta Feg 250 Environmental scanning electron microscope with EDX was 
used to take all images. 
4.2.3.5 Antifungal Testing 
Active dry yeast (Saccharomyces cerevisiae) was used as the model organism for antifungal 
testing. Yeast was added to deionized water at 37˚C under stirring to disperse, and glucose was 




measured as carbon dioxide produced (in mL) using simple water displacement. A small aliquot 
of metal/CNC/tannic acid sample (1 mL, 0.025 wt% w/w) was added to the flask, and the rate of 
respiration (CO2 produced over time) was tracked for a 25 minute period. Control experiments 
were performed using the same protocol, but with 1 mL of deionized water added instead of 
sample. 
4.3 Results and Discussion 
4.3.1 Characterization of Copper/CNC Nanoparticles 
Copper nanoparticles bound to nanocellulose substrates were successfully fabricated using a 
simple one-pot chemical reduction method. Copper sulfate (CuSO4) was used as the metal salt 
precursor, tannic acid (TA) was used as the reducing agent, and cellulose nanocrystals (CNC) 
were used as the capping agent. Tannic acid, a plant polyphenol, has been shown to be an 
effective reducing agent in the synthesis of a variety of metal nanoparticles, as each molecule can 
donate up to 20 electrons to reduce a metal cation [270]. When dispersed in water, tannic acid 
undergoes partial hydrolysis, exposing gallic acid moieties that act as reductants, and glucose 
moieties that act as weak capping agents under basic conditions [268]. For complexation with a 
metal cation, the gallic acid units must be deprotonated, which occurs around pH 8 and above 
[271], [272].  
Previous studies have been undertaken to coat cellulose nanocrystals with tannic acid and 
with other catechol-containing monomers such as dopamine [273], [274]. While the exact 
interaction is not well understood, it has been shown that the oxidized phenolic moieties of 
tannic acid can react with the cellulose nanocrystals to form strong bonds, which may be based 
on covalent, hydrogen, or π–π stacking interactions. To induce a strong coating, the pH of the 
tannic acid and CNC solution in this study was adjusted to 9 using freshly prepared 0.1 M 




to form copper oxide particles on the surface of the CNC. The presence of tannic acid on CNC 
and the formation of copper nanoparticles were monitored using UV-visible spectroscopy 
(Figure 4.1). The UV-visible spectrum of tannic acid is highly pH dependent, and at pH 9, it 
shows two characteristic peaks around 235 and 323 nm [275]. The tannic acid/CNC solution at 
pH 9 generated in this study showed peaks at 254 and 358 nm, indicating relatively good 
agreement with the literature. The composite with copper nanoparticles shows one primary peak 
at 285 nm, which is characteristic of the surface plasmon resonance peak displayed by copper 
oxide nanoparticles [276], [277]. Additionally, a small shoulder at 358 nm can be seen, which is 
indicative of a small amount of unreacted tannic acid remaining in the system. According to 
Mie’s theory, the presence of only one metal-associated peak indicates that the copper oxide 





Figure 4.1: UV-Visible spectra taken at room temperature and native pH for pristine CNC (red), tannic 
acid coated CNC (blue), and copper-nanoparticle coated CNC (black) (A). Photographs of CNC (B) and 
CuCNC (C) dispersions. 
 
The copper/tannic acid/CNC composites (CuCNC) were stable after 5 months storage in 
ambient conditions, with no obvious precipitation and no shift in UV-vis spectrum (indicating 
metal nanoparticle aggregation or agglomeration). The high stability is attributed in large part to 
the colloidal stability of cellulose nanocrystals, which bear highly negative surface charges, and 
thus experience high electrostatic repulsion. The stability of the system was probed using zeta 
potential measurements. A pristine CNC suspension had a zeta potential of -43.6 mV, which 
shows good agreement with previous literature [266]. The zeta potential of the CuCNC 
composite was -25.6 mV, which is still high enough to have good colloidal stability. In contrast, 
copper nanoparticles generated using tannic acid but without CNC as a control had a zeta 
potential of -20.2 mV, which verges on colloidal instability.  
Figure 4.2: TEM images of pristine cellulose nanocrystals (A), tannic acid coated cellulose nanocrystals 
(B), copper nanoparticles generated by tannic acid (C), and copper nanoparticles generated by tannic 




The morphology of the copper composites was examined using a transmission electron 
microscope. Pristine cellulose nanocrystals have very low electron density, and are thus hard to 
visualize with TEM (Fig 4.2A). The addition of the tannic acid coating improves the contract 
somewhat, and a network-like structure can be observed with the tannic acid wrapping the CNC 
closely (Fig 4.2B). The copper-coated CNC show a similar network-like structure, with many 
very small and very well dispersed spherical copper nanoparticles dispersed along the tannic acid 
coated CNC rods. Copper nanoparticles generated tannic acid but without CNC are also 
spherical, but are much larger and have a higher polydispersity, indicating that they are less 
stable and more prone to agglomeration than the CNC-bound copper nanoparticles. 
 
 
4.3.2 Effects of Fabrication Parameters on Copper/CNC Morphology 
Factors such as reaction pH and concentration have been shown to affect the synthesis of metal 
nanoparticles when using tannic acid [279]–[281] , but even in the case where co-reductants such 
as sodium citrate have been used, little previous work has explored the effect of reagent addition 
order on the final material morphology. This study therefore sought to understand how reagent 
addition order might affect the generated CuCNC composite. In order to investigate this, 
copper/CNC composites and controls were fabricated using a variety of reagent addition orders, 
as shown in Scheme 4.1. 
 





Transmission electron microscopy was used to characterize the generated CuCNC 
composites. When tannic acid was added to the CNC dispersion first, followed by the addition of 
NaOH to adjust the pH to 9 and then copper sulfate, the metallization of CNC proceeds as 
expected, yielding many well dispersed copper oxide nanoparticles. However, when copper 
sulfate was added first, a unique ‘bundled’ morphology arose, as shown in Fig. 4.3A. These 
bundles were an average of 54 nm wide and 320 nm long, which is 2 to 5 times the average 
dimensions of pristine cellulose nanocrystals [256], and were coated in small nanoparticles. 
Scanning electron micrographs were also generated of these bundles to assure that the 
morphology was not an artifact of the TEM sample preparation, and very good agreement 
between the two types of micrographs was found (Fig 4.3B). The SEM images also suggest that 
the primary composite is in a ‘bundled’ form, some individual CNC still exist, forming a 
network between the bundles. Elemental analysis was performed directly during SEM 
measurement using EDX, which confirmed the presence of copper. 
To determine the source of the bundling, control experiments were undertaken using 
either just tannic acid and cellulose, or just copper sulfate and cellulose, and following an 
otherwise identical reaction procedure (as laid out in section 4.2.2). These control composites 
were also investigated with TEM imaging. The tannic acid/CNC composite without any copper 
sulfate (Fig 4.3D) showed a simple network structure, similar to those previously observed for 
other catechol-coated CNC composites [273], suggesting that the tannic acid is not the source of 
the bundling. The CuSO4/CNC control (Fig. 4.3C), in contrast, showed nearly identical 
‘bundled’ morphology to the original reversed-fabrication CuCNC composite. Unexpectedly, not 
only did the bundling occur with the addition of CuSO4, but a large number of very small copper 




dark circles in the TEM image. This can be explained by the reductive nature of cellulose 
nanocrystals in basic environments. While tannic acid was used as the primary reducing agent in 
this composite, CNC has previously been shown to generate nanoparticles in a ‘reducant-free’ 
synthesis [92]. The authors of this work proposed that the hydroxyl groups of CNC become 
deprotonated at higher pH, exposing an oxygen anion that can participate in reduction of metal 
nanoparticles. The authors further elaborate that this deprotonation lowers the ability of CNC to 
participate in hydrogen bonding, which means it has higher surface energy and is therefore more 
reactive than at a neutral or acidic pH. 
 
Figure 4.3: TEM and SEM micrographs of bundled copper/CNC colloid (A and B), and TEM 
micrographs of the copper/CNC composite fabricated without tannic acid (C) and without copper sulfate 
(D). The proposed mechanism for bundled or networked colloid formation based on reagent addition 
order (E). 
 
The presence of the bundling only when copper sulfate was added first (with or without 
tannic acid) clarifies that copper cations play a major role in causing the bundled morphology. 
Cellulose nanocrystals generated through sulfuric acid hydrolysis of plant matter bear numerous 
sulfate half ester groups on their surface [282], which impart their characteristic high negative 




oxygen anion. Either of these negatively charged function groups may interact strongly with the 
positive copper cations. The divalency of copper cations also means that they can interact with 
two non-adjacent positively charged sites [283], which could lead to the ‘bridging’ of two CNC 
rods, eventually causing bundling of many CNC rods at once (as shown schematically in Fig. 
4.3E). It can be assumed, in contrast, when CNC is first coated with a tannic acid layer, the 
exposed o-dihydroxyphenyl groups directly chelate and reduce the copper cations to copper 
nanoparticles before any strong electrostatic interactions occur. Thus, changing the order of 
addition of reagents in this system generates vastly different nanostructures from an otherwise 
identical fabrication protocol. 
 
4.3.3 Generation and Characterization of Silver/CNC and Copper/Silver/CNC 
Nanoparticles 
Following the successful fabrication of the copper oxide/CNC composite, a silver/CNC 
composite (AgCNC) was fabricated using the same one-pot method, with tannic acid as the 
reducing agent and cellulose nanocrystals as the capping agent. As with the CuCNC composite, 
tannic acid and colloidal CNC were first combined, and then silver salt precursor (silver nitrate) 
was added dropwise. The solution changed immediately from light orange to dark brown with 
the addition of the silver nitrate. Colloidal suspensions of silver nanoparticles have been shown 
to display a large range of colors, mostly commonly light yellow through dark red or brown 
depending on the shape and concentration [284], [285]. Thus, the visual results of this one-pot 
process are in good agreement with the previous reports. The generated AgCNC nanomaterial 
was stable after 5 months of storage at ambient conditions, with no change in color and no visual 
precipitation. 
Bimetallic composites with both copper and silver bound to CNC (CuAgCNC) were also 




replacement or digestive ripening processes [286]–[288]. Here, the simplest method, chemical 
coreduction, was used. Chemical coreduction has been used successfully to generate bimetallic 
nanoparticles [65], [66], and is advantageous in that it requires no additional preparation steps 
and is very scalable. For the chemical coreduction process, the metal salt precusors are mixed 
prior to the start of the reaction, and then the reduction can proceed unchanged. In this work, 
CuSO4 and AgNO3 were mixed in a 1:1 molar ratio, and added dropwise to a solution of tannic-
acid coated CNC. As with the single metal synthesis, the color of the solution changed 
immediately to a dark brown/black color, indicating the successful synthesis of metal 
nanoparticles. 
The AgCNC and CuAgCNC suspensions were analyzed using UV-visible spectroscopy 
(Fig. 4.4). The characteristic SPR peak of spherical silver nanoparticles ranges between 410 and 
430 nm [289], though the peak wavelength varies based on nanoparticle size and concentration 
[290]. The AgCNC composite displayed a peak at 420 nm, falling well within the expected limits 
for silver nanoparticles. An additional shoulder around 251 nm may be indicative of a small 
amount of residual tannic acid. The CuAgCNC composite showed two distinct peaks at 275 nm 
and 420 nm, aligning nearly perfectly with the copper oxide and silver peaks found for the single 
metal/CNC composites in this study. The relative peak intensity of both the copper and silver 
peak is lower than for the single metal composites, indicating the formation of fewer particles. 
This aligns well with the expected results, as half the amount of each precursor was used for the 





Figure 4.4: UV-Visible spectra for silver/CNC (grey) and copper/silver/CNC (black) composites. 
Copper/CNC spectrum (blue) is show for comparison (A). Photographs of CuCNC (B), AgCNC (C), and 
CuAgCNC (D) dispersions. 
 
Truly alloyed metal nanoparticles generally display only one SPR peak, at a wavelength 
in between those of the two individual metals [291]. Core-shell nanoparticles with a complete 
shell with display only one SPR peak at the same location as the shell’s SPR peak, and core-shell 
nanoparticles with an incomplete shell will display two SPR peaks or ‘humps’ that appear closer 
to each other than the individual peaks for each metal would otherwise be [292], [293]. Colloidal 
solutions of two metal nanoparticles that are not alloyed in any way, but simply mixed, will 
display two peaks at the characteristic locations for each individual metal [294]. The presence of 
two distinct peaks in the location of silver and copper oxide SPR peaks suggest either that the 
chemical coreduction process simply yielded separate copper and silver particles on CNC, rather 
than any type of bimetallic particle. This is likely because there is a large difference in lattice 




that copper/silver core/shell nanoparticles that are not treated with an annealing process post-
fabrication will undergo dewetting, in which the silver nanoparticles form very small free-
floating particles around a bare copper core [68]. 
 
Figure 4.5: TEM micrographs of CuCNC (A) AgCNC (B) and CuAgCNC (C) nanocomposites. All scare 
bars are 100 nm. 
 
To better understand the morphology of the AgCNC and CuAgCNC composites, TEM 
imaging was employed, the results of which are shown in Fig. 4.5. The Ag/CNC composite 
showed similar morphology to the CuCNC composite, with many well dispersed spherical 
nanoparticles generated along a network of tannic acid-coated CNC. Both the CuCNC and 
AgCNC composites show no metal nanoparticles separate from the CNC network, suggesting 
most or all of the nanoparticles are well attached to the substrate. The CuAgCNC composite had 
a markedly different morphology than the single metal and CNC composites, containing a 
bimodal distribution of large (40 nm) darker particles and smaller (<10 nm) lighter particles. 
Based on mass diffraction principles [295], silver nanoparticles should diffract more electrons 
and thus appear darker in brightfield TEM images. However, increased electron diffusion due to 
Bragg’s diffraction off of crystalline materials can also play a large role, confounding the 




presence of crystalline metal. More work to determine the specific composition of the CuAgCNC 
composites is therefore recommended. 
Table 4.1: Measured hydrodynamic and nanoparticle core size and zeta potential for copper- and silver-
containing CNC nanocomposites. 
 
The average sizes and stabilities of the AgCNC and CuAgCNC composites were 
measured and compared with pristine CNC and with CuCNC, as shown in Table 4.1. The 
hydrodynamic diameters, as determined by single angle dynamic light scattering, reflect the total 
size of the composite, including the CNC, the tannic acid coating, and the bound metal 
nanoparticles, and any hydration shell. As expected, the hydrodynamic diameter of each 
metal/CNC colloid is larger than the hydrodynamic diameter of pristine CNC, with the largest 
composite being the AgCNC composite. This larger size may be due to the relatively 
homogenous coating of larger silver nanoparticles, or because of a strong networking between 
some of the individual AgCNC particles, leading to slightly larger agglomerates. The actual 
metal nanoparticle core size was measured using TEM micrographs, and the copper oxide and 
silver nanoparticles from the monometallic composites were found to be quite small (under 10 
nanometers). The average metal core diameter for the CuAgCNC composite was much larger, at 
nearly 25 nm, with a high standard deviation of 21 nm. The high deviation is in part due to the 
bimodality of the system, where some nanoparticles were very small (averaging 11 nm), and 
others very large (upwards of 44 nm). The colloidal stability of the AgCNC and CuAgCNC 




indicating very good stability. This is consistent with the visual aging results, which showed no 
precipitation or sedimentation over a 5 month period in ambient conditions. 
4.3.4 Preliminary Antimicrobial Testing 
To assess the antimicrobial activity of these particles, CuCNC were tested against yeast 
(Saccharomyces cerevisiae), a single-celled eukaryotic model organism. Antifungal testing is a 
facile method for the preliminary evaluation of antimicrobial nanoparticles, and previous work 
has shown extensively that nanoparticles that are antifungal are also antimicrobial [296], [297]. 
Yeast produces carbon dioxide gas (CO2) as a byproduct of normal respiration, and a change in 
the rate of CO2 production can be used to evaluate the health of the yeast. While measurement of 
CO2 produced cannot directly delineate between reduced yeast growth rate and reduced cell 
viability, decrease in fermentation has previously been shown to correlate with both of these 
outcomes [298].  S. cerevisiae treated with 250 µg of CuCNC, which corresponds to a dose of 26 
µg of copper oxide nanoparticles, showed a 40% decrease in respiration with just 25 minutes of 
exposure time (Fig. 4.6). This high rate of respiratory decrease suggests that CuCNC is a highly 
effective antimicrobial agent. 
As previously discussed, metal nanoparticles are well-known to be antimicrobial, and a 
variety of inhibition pathways have been proposed, including the release of toxic heavy metal 
ions and the disruption of the cell membrane due to physical adsorption. Previous work has 
shown that metal nanoparticles bound to cellulose substrates are more antimicrobial than 
comparable free-floating nanoparticles [266]. The authors suggested that the high surface area of 
the cellulose substrate allowed for improved adsorption of the metal/CNC composite on the 
surface of bacteria, inducing more localized release of antimicrobial metal ions. Another recent 
work looking at the toxicity of cellulose-associated copper nanoparticles towards S. cerevisiae 




reactive oxygen species that a copper ion precursor (CuSO4) alone [299], suggesting that the 
CNC plays a large role in increasing the composite’s toxicity. The authors found that the primary 
target of the generated reactive oxygen species was the lipid membrane of the yeast, which 
would an equally attainable target in bacterial model systems. 
As discussed in Chapter 3, smaller nanoparticles are generally expected to be more 
effective at combating Gram negative bacteria, and more negatively charged particles are 
expected to be more effective at combating Gram positive bacteria. Thus, it would be expected 
that the nanocomposites generated in this study, with metal core sizes under 10 nm and zeta 
potentials of -25 mV (somewhat negative) to -47 mV (highly negative) would be highly effective 
as a broad-spectrum antimicrobial agent. The model organism used in this study, yeast, also 
showed susceptibility to CuCNC composites. As the method of antimicrobial activity for 
metal/CNC composites has been shown to target primarily microbial cell membranes, the 
CuCNC, AgCNC, and CuAgCNC composites would all be expected to be highly translatable to 
specific antibacterial applications. 
Figure 4.6: Rate of respiration of yeast (measured as CO2 produced in mL) when allowed to respirate 






This chapter discusses the fabrication and characterization of nanocellulose-bound metal 
nanoparticles generated with a simple and green one-pot method. Tannic acid was successfully 
deposited onto cellulose nanocrystals, and copper, silver, or a combination of copper and silver 
nanoparticles were nucleated onto the substrate with dropwise addition of a metal salt precursor. 
Zeta potential analysis revealed that all of the metal/cellulose nanocrystal composites were 
colloidally stable, with average zeta potentials of -25.5, -47.0, and -33.9 mV for the CuCNC, 
AgCNC, and CuAgCNC nanocomposites, respectively. No agglomeration or precipitation was 
observed for any of the composites over a period of 5 months storage under ambient conditions. 
The copper and CNC composite showed good antimicrobial activity against S. cerevisiae, and 
previous literature indicates this damage may take place through reactive oxygen species 
generation and through physical adsorption and metal ion release. This system provides an 
ecofriendly and facile base for various metal nanoparticles to be fabricated, and the generated 
nanocomposites well suited to antimicrobial applications. Further studies will clarify the 









5.1 Conclusions and Recommendations for Work Presented in 
Chapter 3 
Data mining and meta-analytical techniques were employed for the first time to understand 
larger trends in the efficacy of antimicrobial metal nanoparticles. For this work, over 9,000 
original research articles published between 2015 and 2019 were distilled down into a workable 
body of 600+ articles on single metal antimicrobial nanoparticles. The testing methodologies 
each article used to assess antimicrobial activity were documented, and zone of inhibition tests 
were found to be most common tests used, despite evidence in the literature that this class of 
tests cannot accurately measure the efficacy of nanoparticles. Of the articles published that did 
employ the more robust broth dilution techniques, there was little standardization found in the 
testing or reporting process. A large majority of tests used varying incubation broths, times, and 
temperatures, started with different bacterial inoculums, and tested different species and strains 
of bacteria. Additionally, over two-thirds of the publications included in the data set did not 
report critical information about the testing conditions, such as the bacterial strain or inoculum 
size, or about the material tested, such as its surface charge or shape. 
Simple analysis of variance testing was undertaken to determine the difference in efficacy 
of different metal types, including silver, copper, gold, and zinc nanoparticles. There was a very 
significant (p < 0.01) difference between the efficacy of zinc oxide nanoparticles when compared 
to silver nanoparticles, but no significant different could be found when comparing copper or 
gold nanoparticles to silver. It cannot be concluded at this time whether the lack of significant 
difference is due to the massive variance in the publications, or due to similarity in silver, 
copper, and gold nanoparticles for this application. 
Silver nanoparticles, which represented the focus of over 70% of the publications 




of antimicrobial nanoparticles. When using linear regression models, it was found that the Gram-
type of the bacteria being used as a model is a critical parameter. There was a strong linear 
correlation between size and efficacy for Gram negative bacteria, indicating that Gram-negative 
bacteria are increasingly susceptible to smaller nanoparticles. No such correlation existed for 
Gram-positive bacteria. In contrast, a strong linear correlation existed between surface charge 
and efficacy against Gram-positive bacteria, indicating that more negatively charged particles are 
more effective at damaging Gram-positive bacteria. No such correlation existed for Gram 
negative bacteria. 
The conclusion of this work is therefore twofold. The first conclusion is that the literature 
around antimicrobial metal nanoparticles is yet to be sufficiently standardized, which severely 
limits the ability to draw new and reliable knowledge from the literature. Improvement in the 
testing and reporting standards will be critical in allowing the advancement of the field. The 
second conclusion is that physiochemical parameters such as metal type, nanoparticle size, and 
nanoparticle surface charge do predict the efficacy of the nanoparticles against bacteria. 
However, the Gram type of the bacteria vastly modulates which parameters are important and 
must be considered when designing nanoparticles for specific applications. 
In the future, further statistical modeling could be undertaken to explore the effects of 
size and surface charge on the activity of non-silver nanoparticles, such as gold or copper. This 
could help elucidate whether or not the mechanism(s) of antimicrobial activity are consistent 
across these metals, or whether each one functions differently. Additionally, modeling should be 
performed on the activity of nanoparticles against bacteria aside from S. aureus and E. coli, to 
confirm that the difference in activity is indeed modulated by Gram type, and is not simply 




5.2 Conclusions and Recommendations for Work Presented in 
Chapter 4 
This chapter detailed the fabrication and characterization of cellulose nanocrystal-bound metal 
nanoparticles. Tannic acid and CNC were used for the fabrication of copper, silver, and 
copper/silver metal nanoparticles in mild synthesis conditions, where water was the sole solvent 
and the reaction could proceed at near-room temperature. The system was shown to produce 
relatively monodisperse and highly stable nanoparticles of any metal type tested. The 
nanoparticles had an average size of 5, 7, and 25 nm diameters for the Cu, Ag, and CuAgCNC 
composites, respectively. All composites had a zeta potential of at least -25 mV, indicating good 
colloidal stability, which is attributed in large part to the high stability of cellulose nanocrystals 
themselves.  
 Optimization of the fabrication parameters was undertaken, and the order of reagent 
addition was found to have a large effect on the final product for CuCNC. When copper salt 
precursor and cellulose nanocrystals are mixed prior to the addition of tannic acid, highly 
‘bundled’ CNC structures occur, with copper acting as a crosslinker between adjacent CNC 
molecules. However, the coating of tannic acid on CNC prior to the addition of copper salt 
produces well-dispersed and individual copper coated CNC nanoparticles, due to the direct 
chelation and reduction of copper ions by tannic acid. The pre-coating of CNC with tannic acid 
also works to fabricate silver CNC-bound particles. A mixture of silver and copper nanoparticles 
can be bound simultaneously to tannic acid-coated CNC using simple chemical coreduction. 
 The CuCNC composite was found to have good antimicrobial activity, and is able to 
reduce the activity of yeast after just 25 minutes of contact time with a copper dosing of  
25 µg/mL (total composite dose of 250 µg/mL). It is expected that this antimicrobial activity is 




measurable toxicity at such a low dose. Additionally, copper nanoparticles are likely able to 
generate damaging reactive oxygen species, which can easily cause peroxidation of the lipid 
membranes and therefore cause catastrophic membrane failure in yeast. 
 In conclusion, a simple one-pot and ecofriendly method was shown to produce 
antimicrobial metal/CNC nanocomposites. In the future, more work should be undertaken 
exploring the exact mechanisms of antimicrobial activity for each composite. It would also be 
advantageous to generate bimetallic alloys of silver and copper and compare their activity to 
each individual metal and a mixture of metals. Such work would help to elucidate the 
antibacterial mechanisms and help guide work towards the fabrication of maximally 
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